Author:
Yip King Tuo,Zhong Xue Yin,Seibel Nadia,Pütz Stefanie,Autzen Jasmin,Gasper Raphael,Hofmann Eckhard,Scherkenbeck Jürgen,Stoll Raphael
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Schmidt, J., Riechers, A. & Bosserhoff, A.-K. MIA - a New Target Protein for Malignant Melanoma Therapy. Histol. Histopathol. 28, 421–426 (2012).
2. Bosserhoff, A. et al. Melanoma-inhibiting Activity, a Novel Serum Marker for Progression of Malignant Melanoma. Cancer Res. 3149–3153 (1997).
3. Sanmamed, M. F. et al. Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients. Clin. Chim. Acta. 429, 168–74 (2014).
4. Gogas, H. et al. Biomarkers in melanoma. Ann. Oncol. 20 Suppl 6, vi8–13 (2009).
5. Bosserhoff, A. & Buettner, R. Expression, function and clinical relevance of MIA (Melanoma Inhibitory Activity). Histol. Histopathol. 289–300 (2002).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献